Question 1

How many shares of PTGX does FARALLON CAPITAL MANAGEMENT, L.L.C. own?

Accepted Answer

As of 2026-Q1, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 6.3M shares of PTGX (PROTAGONIST THERAPEUTICS INC).

Question 2

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s PTGX position worth?

Accepted Answer

As of 2026-Q1, FARALLON CAPITAL MANAGEMENT, L.L.C.'s PTGX position is worth $669.2M.

Question 3

Is FARALLON CAPITAL MANAGEMENT, L.L.C. buying or selling PTGX?

Accepted Answer

In 2026-Q1, FARALLON CAPITAL MANAGEMENT, L.L.C. increased their PTGX position (+3.3% change in shares).

Question 4

When did FARALLON CAPITAL MANAGEMENT, L.L.C. first buy PTGX?

Accepted Answer

Based on available 13F filings, FARALLON CAPITAL MANAGEMENT, L.L.C. first reported a position in PTGX in 2024-Q2. They have held the position across 30 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Increased	6.3M	+3.3%	$669.2M	3.8%	$91.30	60
2025-Q4	Decreased	6.1M	-0.8%	$536.6M	2.5%	$87.26	0
2025-Q3	Increased	6.2M	+0.4%	$411.6M	1.7%	$65.14	49
2025-Q2	Increased	6.2M	+1.1%	$341.1M	1.5%	$55.69	49
2025-Q1	Increased	6.1M	+3.0%	$295.3M	1.6%	$48.88	50
2024-Q4	Increased	5.9M	+1.2%	$228.9M	1.2%	$38.51	49
2024-Q3	Increased	5.9M	+0.3%	$263.7M	1.3%	$44.56	49
2024-Q2	Increased	5.8M	+1.8%	$202.4M	1.0%	$34.65	44